Identification of the role of SEL1L in platelet function through a multi-species genetic investigation.

Overview

• This study investigates the role of the protein SEL1L in platelet function across multiple species.
• The research identifies SEL1L as important for platelet adhesion and spreading, linking it to a genetic platelet disorder in horses and demonstrating conserved functions in mice and zebrafish.

Background

• SEL1L is a known component of the endoplasmic reticulum associated degradation (ERAD) pathway, which helps maintain protein quality in cells.
• Although SEL1L is expressed in platelets, its exact functional role had not been established prior to this study.
• Platelets are critical components of blood involved in clot formation and wound healing, with proper adhesion to injury sites being essential for function.

Discovery through Genetic Study of Equine Platelet Disorder

• The research began by studying Atypical Equine Thrombasthenia (AET), an autosomal recessive platelet disorder affecting Thoroughbred horses, characterized by defective platelet function.
• A specific missense mutation in the SEL1L gene (c.1810A>G, causing the amino acid change p.Ile604Val) was identified in horses affected by AET.
• This mutation was shown to correlate with decreased SEL1L protein expression in platelets from the affected horses.
• Investigations revealed that SEL1L, while generally intracellular, relocates to the platelet surface upon activation by thrombin, a protein that stimulates platelets during blood clotting.
• Platelets from horses homozygous for the mutation exhibited impaired spreading on immobilized collagen, indicating defective adhesion and function.

SEL1L in Human Megakaryocytes and Platelets

• Megakaryocytes are bone marrow cells responsible for producing platelets.
• Human megakaryocytes were found to express two isoforms (protein variants) of SEL1L, both of which increase in abundance as the cells mature and develop the platelet-producing machinery.
• Interestingly, only one of these isoforms is transported into circulating mature platelets, suggesting functional specialization during platelet formation.

Functional Validation in Mouse and Zebrafish Models

• To further confirm SEL1L’s role in platelet function, mouse models with inducible knockout (conditional removal) of SEL1L in platelets were studied.
• Complementary studies were conducted on zebrafish, which possess thrombocytes, the functional equivalent of mammalian platelets, with constitutive SEL1L gene knockouts.
• Both models demonstrated that absence of SEL1L led to impaired adhesion of platelets/thrombocytes at sites of endothelial injury, a crucial step in the clotting process.
• This cross-species approach highlights the conserved evolutionary role of SEL1L in hemostasis and platelet-related function.

Implications and Conclusions

• This research uncovers a previously unrecognized function for SEL1L outside its classical role in ER protein quality control, specifically in platelet adhesion and spreading.
• The findings link the ERAD pathway to platelet disorders, exemplified by AET in horses, and potentially relevant to human platelet dysfunction.
• These insights may open new avenues for understanding the molecular basis of platelet-related bleeding disorders and could inform the development of diagnostic or therapeutic strategies targeting SEL1L or related pathways.
• The multi-species genetic approach—from horses to humans, mice, and zebrafish—strengthens the evidence for SEL1L’s conserved role in platelet biology.